NasdaqCM - Nasdaq Real Time Price USD
GlycoMimetics, Inc. (GLYC)
0.2402
-0.0023
(-0.95%)
At close: May 9 at 4:00:00 PM EDT
0.2560
+0.02
+(6.58%)
After hours: May 9 at 6:26:54 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-31,098.0780
-31,098.0780
-34,879.9030
-46,457.4880
-57,489.5300
Investing Cash Flow
20.0280
20.0280
-21.3940
-84.1910
-14.9430
Financing Cash Flow
5.3980
5.3980
28,823.5080
4,157.4080
10,724.3460
End Cash Position
10,720.1780
10,720.1780
41,792.8300
47,870.6190
90,254.8900
Capital Expenditure
-9.9720
-9.9720
-21.3940
-84.1910
-14.9430
Issuance of Capital Stock
0
0
28,707.0110
4,157.4080
10,699.3170
Free Cash Flow
-31,108.0500
-31,108.0500
-34,901.2970
-46,541.6790
-57,504.4730
12/31/2021 - 1/10/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MGNX MacroGenics, Inc.
1.4300
-7.14%
MRSN Mersana Therapeutics, Inc.
0.3189
-4.81%
AZTR Azitra, Inc.
0.2950
-0.97%
CDTX Cidara Therapeutics, Inc.
18.63
-2.72%
SNSE Sensei Biotherapeutics, Inc.
0.3600
-4.41%
KALA KALA BIO, Inc.
3.4200
-0.29%
ASMB Assembly Biosciences, Inc.
12.24
+4.97%
PASG Passage Bio, Inc.
0.3292
-5.02%
INAB IN8bio, Inc.
0.1574
-6.25%
IMCR Immunocore Holdings plc
28.40
-4.67%